Increasing the Dose Intensity of Chemotherapy by More Frequent Administration or Sequential Scheduling: A Patient-L… https://t.co/oAs68gIgt0
@drlw2309 Accelerated regimes were mostly studied in patients on chemo which did not contain antiHer2 agents. https://t.co/AXKPuBGV6H
Aplicable https://t.co/fAljJvVMcU
RT @BacharSamra: Dose dense chemotherapy is the standard of care for early stage #BreastCancer. Patient level meta analysis @TheLancet http…
RT @OICR_news: Towards rational #breastcancer treatment in the era of "less is more" https://t.co/wwN9bjVIgM Dr. John Bartlett reflects on…
Towards rational #breastcancer treatment in the era of "less is more" https://t.co/wwN9bjVIgM Dr. John Bartlett reflects on recent work from the #EBCTCG in @TheLancet https://t.co/LJzVZ6HvNc
RT @TRIOncology: TRIO prides itself on providing high scientific value to all that we do. Data collected in one of our early trials as BCIR…
RT @BacharSamra: Dose dense chemotherapy is the standard of care for early stage #BreastCancer. Patient level meta analysis @TheLancet http…
Dose dense chemotherapy is the standard of care for early stage #BreastCancer. Patient level meta analysis @TheLancet https://t.co/SZeBBz6TVa
RT @weoncologists: Meta analysis at @TheLancet by EBCTCG sees Increasing dose intensity of #adjuvant #chemotherapy by shorter intervals bet…
TRIO prides itself on providing high scientific value to all that we do. Data collected in one of our early trials as BCIRG, continues to provide value to the understanding of the treatment of breast cancer. #cancerresearch https://t.co/BKGvdyDCuI
RT @weoncologists: Meta analysis at @TheLancet by EBCTCG sees Increasing dose intensity of #adjuvant #chemotherapy by shorter intervals bet…
RT @aftimosp: Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-…
RT @weoncologists: Meta analysis at @TheLancet by EBCTCG sees Increasing dose intensity of #adjuvant #chemotherapy by shorter intervals bet…
RT @aftimosp: Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-…
RT @aftimosp: Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-…
RT @aftimosp: Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-…
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials https://t.co/E6sIG0QMp3 #bcsm
RT @weoncologists: Meta analysis at @TheLancet by EBCTCG sees Increasing dose intensity of #adjuvant #chemotherapy by shorter intervals bet…
RT @weoncologists: Meta analysis at @TheLancet by EBCTCG sees Increasing dose intensity of #adjuvant #chemotherapy by shorter intervals bet…
Meta analysis at @TheLancet by EBCTCG sees Increasing dose intensity of #adjuvant #chemotherapy by shorter intervals between cycles or giving drugs sequentially, moderately reduces 10yr risk of recurrence &death from #breastcancer w/o increasing mortal
RT @KarinPurshouse: Ruddy incredible bit of meta-analysis - dose-dense versus standard chemo in early #breastcancer. Sometimes we can impro…
Ruddy incredible bit of meta-analysis - dose-dense versus standard chemo in early #breastcancer. Sometimes we can improve what we have rather than coming up with new ibs and dibs (and woop that this is #openaccess) #oncology #CancerResearch https://t.co/g2
New Research on Breast Cancer #NCDs
RT @VCCLibrary: Increasing the dose intensity of #chemotherapy by more frequent administration or sequential scheduling: a patient-level m…
RT @VCCLibrary: Increasing the dose intensity of #chemotherapy by more frequent administration or sequential scheduling: a patient-level m…
Increasing the dose intensity of #chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early #breastcancer in 26 randomised trials https://t.co/XzQW1JYsza #Cancer
RT @NatRevClinOncol: Increasing the dose intensity of adjuvant chemotherapy moderately reduces the 10-year risk of recurrence and death fro…
RT @matteolambe: The #EBCTCG metanalysis on efficacy of increasing dose intensity of #chemotherapy in early #BreastCancer patients presente…
RT @NatRevClinOncol: Increasing the dose intensity of adjuvant chemotherapy moderately reduces the 10-year risk of recurrence and death fro…
RT @NatRevClinOncol: Increasing the dose intensity of adjuvant chemotherapy moderately reduces the 10-year risk of recurrence and death fro…
RT @NatRevClinOncol: Increasing the dose intensity of adjuvant chemotherapy moderately reduces the 10-year risk of recurrence and death fro…
Increasing the dose intensity of adjuvant chemotherapy moderately reduces the 10-year risk of recurrence and death from #breastcancer without increasing mortality from other causes: https://t.co/wKEcYM6Gpe #bcsm
RT @m0370: 早期乳癌の術前術後化学療法で、dose intensityレジメンと標準レジメンの26試験・3.7万人の統合解析。(intense群には2週回しやアンスラタキサン同時使用など幾つかあり)。3週と2週では17%再発抑制。ER陰性で特に恩恵が大きい。Lance…
RT @m0370: 早期乳癌の術前術後化学療法で、dose intensityレジメンと標準レジメンの26試験・3.7万人の統合解析。(intense群には2週回しやアンスラタキサン同時使用など幾つかあり)。3週と2週では17%再発抑制。ER陰性で特に恩恵が大きい。Lance…
RT @m0370: 早期乳癌の術前術後化学療法で、dose intensityレジメンと標準レジメンの26試験・3.7万人の統合解析。(intense群には2週回しやアンスラタキサン同時使用など幾つかあり)。3週と2週では17%再発抑制。ER陰性で特に恩恵が大きい。Lance…
RT @m0370: 早期乳癌の術前術後化学療法で、dose intensityレジメンと標準レジメンの26試験・3.7万人の統合解析。(intense群には2週回しやアンスラタキサン同時使用など幾つかあり)。3週と2週では17%再発抑制。ER陰性で特に恩恵が大きい。Lance…
RT @m0370: 早期乳癌の術前術後化学療法で、dose intensityレジメンと標準レジメンの26試験・3.7万人の統合解析。(intense群には2週回しやアンスラタキサン同時使用など幾つかあり)。3週と2週では17%再発抑制。ER陰性で特に恩恵が大きい。Lance…
RT @m0370: 早期乳癌の術前術後化学療法で、dose intensityレジメンと標準レジメンの26試験・3.7万人の統合解析。(intense群には2週回しやアンスラタキサン同時使用など幾つかあり)。3週と2週では17%再発抑制。ER陰性で特に恩恵が大きい。Lance…
RT @m0370: 早期乳癌の術前術後化学療法で、dose intensityレジメンと標準レジメンの26試験・3.7万人の統合解析。(intense群には2週回しやアンスラタキサン同時使用など幾つかあり)。3週と2週では17%再発抑制。ER陰性で特に恩恵が大きい。Lance…
早期乳癌の術前術後化学療法で、dose intensityレジメンと標準レジメンの26試験・3.7万人の統合解析。(intense群には2週回しやアンスラタキサン同時使用など幾つかあり)。3週と2週では17%再発抑制。ER陰性で特に恩恵が大きい。Lancetにしては珍しく全文フリー。 /Lancet https://t.co/lB277n9kgF
RT @TheLancet: Increasing the dose intensity of #chemotherapy by shortening the interval btw treatment cycles, or by giving individual drug…
RT @TheLancet: Increasing the dose intensity of #chemotherapy by shortening the interval btw treatment cycles, or by giving individual drug…
RT @TheLancet: Increasing the dose intensity of #chemotherapy by shortening the interval btw treatment cycles, or by giving individual drug…
RT @PeterHall001: Long awaited this meta-analysis of dose intense chemo for early BC. https://t.co/kKAE0r9g8l
RT @jesusanampa: Meta-analysis of adjuvant chemotherapy: Increasing the dose intensity of chemotherapy decreases recurrence or #breastcanc…
Meta-analysis of adjuvant chemotherapy: Increasing the dose intensity of chemotherapy decreases recurrence or #breastcancer mortality by 23% #BCSM @TheLancet https://t.co/INGBMSpKol breastcancer
RT @pozoparilli: Resultados relevantes de disminución de mortalidad en las pacientes con cáncer de mama, 10 a 15% mejor en tratamientos Qt…
RT @TheLancet: Increasing the dose intensity of #chemotherapy by shortening the interval btw treatment cycles, or by giving individual drug…
New evidence on #NCDs treatment strategies. #BreastCancer
RT @TheLancet: Increasing the dose intensity of #chemotherapy by shortening the interval btw treatment cycles, or by giving individual drug…
Increasing the dose intensity of #chemotherapy by shortening the interval btw treatment cycles, or by giving individual drugs sequentially, moderately reduces the 10-year risk of recurrence and death from #breastcancer - NEW research https://t.co/rUaEXlVM0
RT @pozoparilli: Resultados relevantes de disminución de mortalidad en las pacientes con cáncer de mama, 10 a 15% mejor en tratamientos Qt…
RT @matteolambe: The #EBCTCG metanalysis on efficacy of increasing dose intensity of #chemotherapy in early #BreastCancer patients presente…
RT @MTCOSB: 乳がんdose-dense chemotherapy(PEG G-CSF の力で3週→2週)の有用性を示したpooled analysis. 全体にdose-denseがよい。印象通り70歳以下、ホルモン受容体陰性、リンパ節陽性には積極的に実施したい印象…
RT @TheLancet: NEW Research—Increasing the dose intensity of #chemotherapy by more frequent administration or sequential scheduling: a pati…
RT @TheLancet: NEW Research—Increasing the dose intensity of #chemotherapy by more frequent administration or sequential scheduling: a pati…
乳がんdose-dense chemotherapy(PEG G-CSF の力で3週→2週)の有用性を示したpooled analysis. 全体にdose-denseがよい。印象通り70歳以下、ホルモン受容体陰性、リンパ節陽性には積極的に実施したい印象。 https://t.co/SCWVUo7Pdt
NEW Research—Increasing the dose intensity of #chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early #breastcancer in 26 randomised trials https://t.co/uWNFXREQJp
RT @pozoparilli: Resultados relevantes de disminución de mortalidad en las pacientes con cáncer de mama, 10 a 15% mejor en tratamientos Qt…
RT @GarbineLizeaga: "[Articles] Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a p…
RT @pozoparilli: Resultados relevantes de disminución de mortalidad en las pacientes con cáncer de mama, 10 a 15% mejor en tratamientos Qt…
RT @matteolambe: The #EBCTCG metanalysis on efficacy of increasing dose intensity of #chemotherapy in early #BreastCancer patients presente…
RT @matteolambe: The #EBCTCG metanalysis on efficacy of increasing dose intensity of #chemotherapy in early #BreastCancer patients presente…
RT @PeterHall001: Long awaited this meta-analysis of dose intense chemo for early BC. https://t.co/kKAE0r9g8l
Long awaited this meta-analysis of dose intense chemo for early BC. https://t.co/kKAE0r9g8l
RT @matteolambe: The #EBCTCG metanalysis on efficacy of increasing dose intensity of #chemotherapy in early #BreastCancer patients presente…
An analysis of data from 37,000 women with early breast cancer in 26 randomised trials, has found shortening the interval between chemotherapy cycles from 3-weeks to 2-weeks moderately reduces the 10-year risk of breast cancer returning. https://t.co/yl62R
RT @matteolambe: The #EBCTCG metanalysis on efficacy of increasing dose intensity of #chemotherapy in early #BreastCancer patients presente…
RT @pozoparilli: Resultados relevantes de disminución de mortalidad en las pacientes con cáncer de mama, 10 a 15% mejor en tratamientos Qt…
RT @pozoparilli: Resultados relevantes de disminución de mortalidad en las pacientes con cáncer de mama, 10 a 15% mejor en tratamientos Qt…
Resultados relevantes de disminución de mortalidad en las pacientes con cáncer de mama, 10 a 15% mejor en tratamientos Qt con aumento en la intensidad de la dosis que en los esquemas tradicionales. Esquema ideal, toxicidad, tolerancia, escoger las paciente
RT @matteolambe: The #EBCTCG metanalysis on efficacy of increasing dose intensity of #chemotherapy in early #BreastCancer patients presente…
RT @matteolambe: The #EBCTCG metanalysis on efficacy of increasing dose intensity of #chemotherapy in early #BreastCancer patients presente…
RT @matteolambe: The #EBCTCG metanalysis on efficacy of increasing dose intensity of #chemotherapy in early #BreastCancer patients presente…
RT @matteolambe: The #EBCTCG metanalysis on efficacy of increasing dose intensity of #chemotherapy in early #BreastCancer patients presente…
RT @matteolambe: The #EBCTCG metanalysis on efficacy of increasing dose intensity of #chemotherapy in early #BreastCancer patients presente…
RT @matteolambe: The #EBCTCG metanalysis on efficacy of increasing dose intensity of #chemotherapy in early #BreastCancer patients presente…
RT @matteolambe: The #EBCTCG metanalysis on efficacy of increasing dose intensity of #chemotherapy in early #BreastCancer patients presente…
RT @matteolambe: The #EBCTCG metanalysis on efficacy of increasing dose intensity of #chemotherapy in early #BreastCancer patients presente…
RT @matteolambe: The #EBCTCG metanalysis on efficacy of increasing dose intensity of #chemotherapy in early #BreastCancer patients presente…
RT @matteolambe: The #EBCTCG metanalysis on efficacy of increasing dose intensity of #chemotherapy in early #BreastCancer patients presente…
RT @matteolambe: The #EBCTCG metanalysis on efficacy of increasing dose intensity of #chemotherapy in early #BreastCancer patients presente…
RT @matteolambe: The #EBCTCG metanalysis on efficacy of increasing dose intensity of #chemotherapy in early #BreastCancer patients presente…
RT @matteolambe: The #EBCTCG metanalysis on efficacy of increasing dose intensity of #chemotherapy in early #BreastCancer patients presente…
RT @matteolambe: The #EBCTCG metanalysis on efficacy of increasing dose intensity of #chemotherapy in early #BreastCancer patients presente…
RT @matteolambe: The #EBCTCG metanalysis on efficacy of increasing dose intensity of #chemotherapy in early #BreastCancer patients presente…
RT @matteolambe: The #EBCTCG metanalysis on efficacy of increasing dose intensity of #chemotherapy in early #BreastCancer patients presente…
RT @matteolambe: The #EBCTCG metanalysis on efficacy of increasing dose intensity of #chemotherapy in early #BreastCancer patients presente…
RT @matteolambe: The #EBCTCG metanalysis on efficacy of increasing dose intensity of #chemotherapy in early #BreastCancer patients presente…
The #EBCTCG metanalysis on efficacy of increasing dose intensity of #chemotherapy in early #BreastCancer patients presented at #SABCS17 now published in @TheLancet: important contribution of @delmastro_lucia from @UniGenova @SanMartino_Ge and #GIM group h
RT @GarbineLizeaga: "[Articles] Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a p…
RT @GarbineLizeaga: "[Articles] Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a p…
RT @GarbineLizeaga: "[Articles] Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a p…
RT @GarbineLizeaga: "[Articles] Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a p…
"[Articles] Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials" https://t.co/TMlTvtyw7G
RT @adelapoite: Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level met…
RT @adelapoite: Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level met…
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials - The Lancet https://t.co/4dsFs8EwC2
RT @OICR_news: Dr. John Bartlett & the #EBCTCG in @TheLancet: Increasing dose intensity of #chemotherapy by more frequent administration or…